Netherlands· NL-1ab3d96e6c8c
NeisVac-C, suspensie voor injectie in een voorgevulde spuit
A meningokokkus c, gereinigtes polysaccharid-antigen, konjugiert product containing tetanus conjugaat van meningococcen (stam c11) polysaccharide, groep c, registered in Netherlands by Pfizer B.V.. The same ATC class is registered in 6 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Meningokokkus c, gereinigtes polysaccharid-antigen, konjugiert is registered in 6 of 19 countries.
Countries holding a registration under ATC J07AH07 (meningokokkus c, gereinigtes polysaccharid-antigen, konjugiert), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 4 of them publish a price we can compare per daily dose
Meningokokkus c, gereinigtes polysaccharid-antigen, konjugiert · ATC J07AH07
6 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- TETANUS CONJUGAAT VAN MENINGOCOCCEN (Stam C11) POLYSACCHARIDE, GROEP C
- Manufacturer
- Pfizer B.V.
- Country
- Netherlands (NL)
- ATC code
- J07AH07
- ATC class
- Meningokokkus C, gereinigtes Polysaccharid-Antigen, konjugiert
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id26343
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AH07
Meningokokkus c, gereinigtes polysaccharid-antigen, konjugiert, as other registers publish it.
- BelgiumMeningitec 10 µgNuron Biotech
- FinlandMenjugateNovartis Vaccines and Diagnostics S.r.l.
- FinlandMenjugateGlaxosmithkline Vaccines S.r.l.
- FinlandMenjugateGlaxosmithkline Vaccines S.r.l.
- BelgiumMenjugate 10 µgGSK Vaccines
- BelgiumMenjugate 10 µgGSK Vaccines
- FinlandMenjugate KitGlaxosmithkline Vaccines S.r.l.
- FinlandNeisvac-CPfizer Oy
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e04a5d2d-174e-4255-a5f6-efdaea5bc644 GET /v1/drugs/e04a5d2d-174e-4255-a5f6-efdaea5bc644?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Suspensie voor injectie",
"route": "Intramusculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h26343_smpc.pdf",
"strength": null,
"atc_label": "Meningococcus C, Purified Polysaccharides Antigen Conjegated",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg26343",
"excipients": [
"ALUMINIUMHYDROXIDE, GEHYDRATEERD, VOOR ADSORPTIE",
"NATRIUMCHLORIDE",
"WATER VOOR INJECTIE"
],
"substances": [
"TETANUS CONJUGAAT VAN MENINGOCOCCEN (Stam C11) POLYSACCHARIDE, GROEP C"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h26343.pdf",
"authorised_at": "2001/06/27",
"procedure_number": "BE/H/0290/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "26343",
"additional_monitoring": "N"
}See everything about meningokokkus c, gereinigtes polysaccharid-antigen, konjugiert.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.